PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)

被引：0
|
作者：
Chiney, M. S. [1 ]
Polepally, A. R. [1 ]
Nader, A. M. [1 ]
Dufek, M. B. [1 ]
Klein, C. E. [1 ]
Ng, J. W. [1 ]
Shebley, M. [1 ]
机构：
[1] Abbvie, N Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-022
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [1] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Duan, Peng
    Zhao, Ping
    Zhang, Lei
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 689 - 705
  • [2] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Peng Duan
    Ping Zhao
    Lei Zhang
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 689 - 705
  • [3] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING (PBPK) OF PITAVASTATIN AND ATORVASTATIN TO PREDICT DRUG-DRUG INTERACTIONS (DDIS).
    Duan, P.
    Zhao, P.
    Zhang, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S16 - S17
  • [4] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF DISPOSITION AND DRUG-DRUG INTERACTIONS FOR VALPROIC ACID/DIVALPROEX
    Reed, R.
    Conner, T.
    Zhang, T.
    [J]. EPILEPSIA, 2017, 58 : S158 - S159
  • [5] Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
    Ji, Beihong
    Liu, Shuhan
    Xue, Ying
    He, Xibing
    Viet Hoang Man
    Xie, Xiang-Qun
    Wang, Junmei
    [J]. DRUGS IN R&D, 2019, 19 (03) : 297 - 305
  • [6] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [7] Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
    Chiney, Manoj S.
    Ng, Juki
    Gibbs, John P.
    Shebley, Mohamad
    [J]. CLINICAL PHARMACOKINETICS, 2020, 59 (05) : 617 - 627
  • [8] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Ruijuan Xu
    Weihong Ge
    Qing Jiang
    [J]. European Journal of Clinical Pharmacology, 2018, 74 : 755 - 765
  • [9] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Xu, Ruijuan
    Ge, Weihong
    Jiang, Qing
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (06) : 755 - 765
  • [10] Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions
    Baneyx, Guillaume
    Fukushima, Yumi
    Parrott, Neil
    [J]. FUTURE MEDICINAL CHEMISTRY, 2012, 4 (05) : 681 - 693
12345